Natural Killer Cells Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028
Natural Killer Cells Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028
Report Digest
Natural Killer Cells Therapeutics Market: Overview
Natural killer cells are generally big granular lymphocytes. These cells react quickly to any pathological problem. In addition to this, these natural killer cells are responsible for the production of immunoregulatory cytokines. Also, these natural killer cells act as a key component of the overall immune system of the humans. The role of these natural killer cells is the produce a quick immune response against different types of infections and malignancies.
Natural Killer Cells Therapeutics Market: Notable Developments
Some of the key developments in the global natural killer cells therapeutics market are given below:
- In August 2019, Celgene Corporation announced that the company has been successful in getting the approval from the US Food and Drug Administration for the introduction of INREBI® (fedratinib). This new drug is curated to treat adults who are suffering from high-risk primary or secondary or intermediate-2 or myelofibrosis.
- In August 2018, Affimed NV announced that the company has entered into a strategic agreement of collaborating with Genetech. Genetech is a prominent brand under Roche Group. The objective behind the agreement is to develop, commercialize, and market new natural killer engager-based immunotherapeutics for the treatment of different types of cancer.
Natural Killer Cells Therapeutics Market: Drivers and Restraints
There are numerous factors that are exerting a strong influence on the overall development of the global natural killer cells therapeutics market. One of the key driving factors for the growth of the market have been the increasing adoption of these natural killer cells for the treatment of various disease include liver diseases, infections, and cancer. In addition to this, these natural killer cells play a crucial role in the immune surveillance of tumor that pushes the adoption natural killer cells therapeutics across the world.
There are however, some factors that may derail the growth of the global natural killer cells therapeutics market. Adverse side effects, poor in-vivo therapies, and lack of certainty have been the key restraining factor for the growth of the natural killer cells therapeutics market.
Nonetheless, the growing awareness about the several immunotherapies has also been a crucial factor for the growth of the global natural killer cells therapeutics market. Moreover, the increased funding and investments for the research and development activities has played in developing newer therapeutics and expanding the reach of the market even further.
Natural Killer Cells Therapeutics Market: Geographical Outlook
In terms of geographical segmentation, the global natural killer cells therapeutics market has five key regions viz. North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of these, the natural killer cells therapeutics market is currently dominated by the North America region. The region is also expected to continue to lead the global market over the course of the given forecast period of 2018 to 2028. The growth of the North America natural killer cells therapeutics market is mainly attributed to the considerable growth of the in the prevalence of cancer in the region.
However, the region of Asia Pacific is expected to exhibit a higher CAGR over the course of the given forecast period. This high growth of the market in the region is down to the presence of emerging economies such as India and China. These developing nations are spending heavily on the development of their medical and healthcare infrastructure. This has led to increasing funding for research and development activities that has ultimately benefitted the growth of the natural killer cells therapeutics market.
Natural Killer Cells Therapeutics Market Segments:
By Therapeutics
- NK Cell Therapies
- NK Cell Directed Antibodies
By Application
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
- Others
By End User
- Research Centers & Institutes
- Hospitals
- Others
The study presents a granular assessment and quantitative evaluation of:
- Key growth factors and prominent trends
- Size and share of key segments in overall market
- Key challenges and winning imperatives
- Factors shaping competitive landscape
- Insights into how contours of market will change in coming years
- Technological advances
- New avenues and imminent investment pockets
- Regulatory landscape shaping current and future strategies of companies
The region-wise assessment includes market dynamics in:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
- Which key factors will shape the competitive landscape?
- Which trends will stimulate research and development activities in different geographies?
- Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
- Which disruptions in market growth are likely to come with the new business models?
- Which are some of the recent overhauls in policies that may change the course of the market significantly?
- Which are the geographies that will form sizable sources of new streams to new and established players alike?
- How are top players likely to realign their strategy to counter the forces of competition?
- Which key strategies emerging players are likely to focus on to consolidate their position?
- Which changes in end-user preferences might affect the status quo held by the leading players?
- Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report